Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
766
archived clinical trials in
Cosmetic

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
El Paso, TX
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Houston, TX
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Pflugerville, TX
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Pflugerville, TX
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Plano, TX
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
San Antonio, TX
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Arlington, VA
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Arlington, VA
Click here to add this to my saved trials
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated:  11/29/2016
Clinical Research Facility
mi
from
Norfolk, VA
A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Status: Enrolling
Updated: 11/29/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Registry of Mastectomy for Breast Cancer Risk Reduction
Registry of Mastectomy for Breast Cancer Risk Reduction
Status: Enrolling
Updated:  12/1/2016
Georgetown University Hospital
mi
from
Washington,
Registry of Mastectomy for Breast Cancer Risk Reduction
Registry of Mastectomy for Breast Cancer Risk Reduction
Status: Enrolling
Updated: 12/1/2016
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
Status: Enrolling
Updated:  12/15/2016
Dermatology Consultants Inc
mi
from
High Point, NC
Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
Status: Enrolling
Updated: 12/15/2016
Dermatology Consultants Inc
mi
from
High Point, NC
Click here to add this to my saved trials
Oral Cleft Prevention Program
Oral Cleft Prevention Program
Status: Enrolling
Updated:  3/30/2017
University of Iowa
mi
from
Iowa City, IA
Oral Cleft Prevention Program
Oral Cleft Prevention Program
Status: Enrolling
Updated: 3/30/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Azeliac Acid Gel and Active Treatments to a Placebo Control in the Treatment of Moderate Facial Rosacea.
Status: Enrolling
Updated:  5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Azeliac Acid Gel and Active Treatments to a Placebo Control in the Treatment of Moderate Facial Rosacea.
Status: Enrolling
Updated: 5/3/2017
Taro Pharmaceuticals USA Inc.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea
Status: Enrolling
Updated:  5/10/2017
Clinical Research Facility
mi
from
Boston, MA
Preferences & Treatment Satisfaction Drivers in Rosacea Patients
A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea
Status: Enrolling
Updated: 5/10/2017
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials
Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials
Status: Enrolling
Updated:  6/19/2017
University of California, Davis Medical Center
mi
from
Sacramento, CA
Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials
Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials
Status: Enrolling
Updated: 6/19/2017
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
Aquacel vs. Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage: A Randomized Control Study
Status: Enrolling
Updated:  9/5/2017
Maricopa Integrated Health System
mi
from
Phoenix, AZ
Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage
Aquacel vs. Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage: A Randomized Control Study
Status: Enrolling
Updated: 9/5/2017
Maricopa Integrated Health System
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Pilot Trial to Assess the Impact of Acupuncture on Post-mastectomy Pain, Nausea, Anxiety and Ability to Cope
A Pilot Randomized Controlled Trial to Assess the Impact of Acupuncture on Post-mastectomy Pain, Nausea, Anxiety and Ability to Cope.
Status: Enrolling
Updated:  9/6/2017
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
A Pilot Trial to Assess the Impact of Acupuncture on Post-mastectomy Pain, Nausea, Anxiety and Ability to Cope
A Pilot Randomized Controlled Trial to Assess the Impact of Acupuncture on Post-mastectomy Pain, Nausea, Anxiety and Ability to Cope.
Status: Enrolling
Updated: 9/6/2017
Abbott Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
A Multicenter, Randomized Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in the Treatment of Cellulitis or Erysipelas
Status: Enrolling
Updated:  9/6/2017
Joseph Still Research Foundation
mi
from
Augusta, GA
Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
A Multicenter, Randomized Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in the Treatment of Cellulitis or Erysipelas
Status: Enrolling
Updated: 9/6/2017
Joseph Still Research Foundation
mi
from
Augusta, GA
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
Vitiligo and Pigmentation Inst of Southern California
mi
from
Los Angeles, CA
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
Vitiligo and Pigmentation Inst of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
Skin Care research Inc
mi
from
Boca Raton, FL
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
Skin Care research Inc
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
Dermatology Research Institute
mi
from
Coral Gables, FL
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
Dermatology Research Institute
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
International Dermatology Research, Inc.
mi
from
Miami, FL
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
William Coleman, M.D.
mi
from
Metairie, LA
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
William Coleman, M.D.
mi
from
Metairie, LA
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
Academic Dermatology Associates
mi
from
Albuquerque, NM
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
Academic Dermatology Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
St. Lukes Roosevelt
mi
from
New York, NY
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
St. Lukes Roosevelt
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
Tenneesee Clinical Research Center
mi
from
Nashville, TN
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
Tenneesee Clinical Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated:  9/15/2017
Derm Research, Inc
mi
from
Austin, TX
Safety Study of Cosmetic Tissue Augmentation in People of Color
A Post Approval, Multicenter, Open-Label, Longitudinal, Uncontrolled Safety Study of Cosmetic Tissue Augmentation Product (ELEVESS™) in the Treatment of Nasolabial Folds in People of Color
Status: Enrolling
Updated: 9/15/2017
Derm Research, Inc
mi
from
Austin, TX
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Clinical Testing of Beverly Hills
mi
from
Beverly Hills, CA
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Clinical Testing of Beverly Hills
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Dermatology Specialists, Inc
mi
from
Murrieta, CA
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Dermatology Specialists, Inc
mi
from
Murrieta, CA
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Dermatology Specialists, Inc.
mi
from
Oceanside, CA
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Dermatology Specialists, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Dermatology Cosmetic Laser Medical Associates of LaJolla, Inc.
mi
from
San Diego, CA
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Dermatology Cosmetic Laser Medical Associates of LaJolla, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Olympian Clinical Research
mi
from
Clearwater, FL
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Olympian Clinical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Olympian Clinical Research
mi
from
Clearwater, FL
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Olympian Clinical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Skin Research Institute
mi
from
Coral Gables, FL
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Skin Research Institute
mi
from
Coral Gables, FL
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Research Institute of the Southeast
mi
from
West Palm Beach, FL
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Research Institute of the Southeast
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Mercy Health Research
mi
from
Washington, MO
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Mercy Health Research
mi
from
Washington, MO
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Bass Plastic Surgery PLLC
mi
from
New York, NY
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Bass Plastic Surgery PLLC
mi
from
New York, NY
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Sadick Research Group
mi
from
New York, NY
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Sadick Research Group
mi
from
New York, NY
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Dermatology Consulting Services
mi
from
High Point, NC
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Tennessee Clinical Research Center
mi
from
Nashville, TN
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Tennessee Clinical Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Austin Institute for Clinical Research, Inc.
mi
from
Pflugerville, TX
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Austin Institute for Clinical Research, Inc.
mi
from
Pflugerville, TX
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
The Education and Research Foundation, Inc.
mi
from
Lynchburg, VA
Click here to add this to my saved trials
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated:  10/4/2017
Premier Clinical Research
mi
from
Spokane, WA
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)
Status: Enrolling
Updated: 10/4/2017
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal
Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal
Status: Enrolling
Updated:  10/17/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal
Pilot Study Evaluating Characteristic Closure Patterns of the Normal Velopharyngeal Portal
Status: Enrolling
Updated: 10/17/2017
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
The Effect of Reusable Versus Disposable Draping on Implant Based Breast Reconstruction Infection Rates: a Prospective Randomized Study
Status: Enrolling
Updated:  11/3/2017
Wake Forest University Baptist Medical Center Plastic & Reconstructive Surgery Department
mi
from
Winston-Salem, NC
Reusable Versus Disposable Draping System in Breast Reconstruction Surgery
The Effect of Reusable Versus Disposable Draping on Implant Based Breast Reconstruction Infection Rates: a Prospective Randomized Study
Status: Enrolling
Updated: 11/3/2017
Wake Forest University Baptist Medical Center Plastic & Reconstructive Surgery Department
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Retrospective Study to Evaluate the Effectiveness of the Ulthera System
Retrospective Evaluation of the Ulthera System for Lifting and Tightening of the Face and Neck
Status: Enrolling
Updated:  11/10/2017
Dermatology Cosmetic Laser Associates
mi
from
San Diego, CA
A Retrospective Study to Evaluate the Effectiveness of the Ulthera System
Retrospective Evaluation of the Ulthera System for Lifting and Tightening of the Face and Neck
Status: Enrolling
Updated: 11/10/2017
Dermatology Cosmetic Laser Associates
mi
from
San Diego, CA
Click here to add this to my saved trials
Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck
Feasibility Study: Evaluation of the Ulthera® System vs Thermage® for Lifting and Tightening of the Full Face and Neck
Status: Enrolling
Updated:  11/21/2017
FACES+
mi
from
San Diego, CA
Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck
Feasibility Study: Evaluation of the Ulthera® System vs Thermage® for Lifting and Tightening of the Full Face and Neck
Status: Enrolling
Updated: 11/21/2017
FACES+
mi
from
San Diego, CA
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Johnson Dermatology
mi
from
Fort Smith, AR
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Johnson Dermatology
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Blue Harbor Dermatology
mi
from
Newport Beach, CA
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Blue Harbor Dermatology
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Center for Dermatology & Laser Surgery
mi
from
Sacramento, CA
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Center for Dermatology & Laser Surgery
mi
from
Sacramento, CA
Click here to add this to my saved trials
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated:  11/21/2017
Redwood Dermatology Research
mi
from
Santa Rosa, CA
Mirvaso in Use Study
MIRVASO® In Use Study: Managing Rosacea Through Assessment and Control of Its Erythema (The MIRACLE Study)
Status: Enrolling
Updated: 11/21/2017
Redwood Dermatology Research
mi
from
Santa Rosa, CA
Click here to add this to my saved trials